Accès ouvert

Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era

Article scientifique 2021 Anglais

Résumé

Background: Injectable contraceptives are fast becoming the method of choice among women in sub-Saharan Africa (SSA). Specifically, the subcutaneously administered depot–medroxyprogesterone acetate (DMPA-SC) is gaining traction as a convenient, private and effective method to address unmet need for family planning (FP). The objective of this study was to determine the trend in DMPA-SC use in Nigeria. Methods: Data was extracted from the National Health Management Information System (NHMIS) FP register on DMPA-SC uptake in public health facilities and through community-oriented resource providers (CORPS) in 10 Nigerian states. The linear trend model was adopted in data analysis based on lowest measure of dispersion and/or highest adjusted coefficient of determination (R 2 ). The statistical significance was determined at 5%. Results: There was an upward trend in the use of DMPA-SC among clients who received the service through health providers, CORPS and self-injection in the 10 project states over a period of 12 months (August 2019–July 2020). In addition, the linear trend model showed that for every unit increase in months, the average number of women expected to use DMPA-SC through health providers, CORPS and self-injection will increase by 1308.3 (Yt = 3799.7 +1308.3*t), 756.73 (Yt = − 1030.8 +756.73*t) and 77.864 (Yt = − 159.7 +77.864*t) respectively. In all models, the adjusted coefficient of determination was 99.9% which showed good model fitness. The results also showed that the number of DMPA-SC clients varied across the project states with Niger (32,988) and Oyo (31,511) states reporting the highest number of clients over the period of 12 months. Conclusion: There was an increasing use of DMPA-SC and self–injection among clients over time. Health facility and community-based FP programs should be strengthened to ensure improved access to FP services. Keywords: family planning, contraceptive, Nigeria, DMPA-SC, self-injection, birth control

Citer ce document

Osinowo, K., Sambo-Donga, F., Ojomo, O., Ibitoye, S., Oluwayemi, P., Okunfulure, M., Ladipo, O., Ekholuenetale, M. (2021). Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era. https://doi.org/10.2147/oajc.s326106

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Kehinde Osinowo Fintirimam Sambo-Donga Oluwaseun Ojomo Segun Emmanuel Ibitoye Philip Oluwayemi Morounfola Okunfulure O. A. Ladipo Michael Ekholuenetale

Statistiques

Consultations : 1

Téléchargements : 0